Novo Nordisk A/S
NONOF
$49.68
$0.160.32%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.89% | -22.10% | 39.35% | 10.71% | 27.24% |
| Total Depreciation and Amortization | 62.07% | 70.35% | 117.26% | 71.93% | 213.76% |
| Total Amortization of Deferred Charges | 36.01% | -- | -- | -- | 18.52% |
| Total Other Non-Cash Items | -47.34% | 14.68% | -69.73% | 316.98% | -1,181.20% |
| Change in Net Operating Assets | 63.32% | 53.19% | -49.14% | -65.65% | 224.48% |
| Cash from Operations | -32.45% | 11.77% | -14.86% | 66.44% | 27.50% |
| Capital Expenditure | -24.83% | -19.54% | -47.62% | -53.45% | -69.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 101.34% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -533.91% | 78.26% | 104.54% | -47.40% | 218.96% |
| Cash from Investing | 48.81% | 21.56% | 27.55% | -263.42% | -513.58% |
| Total Debt Issued | -31.59% | 499.16% | 31.07% | -- | -- |
| Total Debt Repaid | -166.28% | -115.41% | -1,183.53% | -3,695.58% | -21.97% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | 100.00% | 100.00% | 51.06% | 23.26% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -13.67% | -- | -19.67% | -- |
| Other Financing Activities | -- | -- | -402.67% | 402.67% | -- |
| Cash from Financing | -12.75% | 1.24% | -392.13% | 120.02% | 460.47% |
| Foreign Exchange rate Adjustments | -83.88% | 119.24% | -2,133.13% | -289.35% | 439.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.18% | 245.71% | -146.49% | 379.58% | -164.33% |